Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders

All proposals approvedCompany announces 1-for-75 reverse stock split to support compliance with Nasdaq listing standardsShares of Jaguar Health common stock to begin trading on split-adjusted basis on January 23, 2023Patient enrollment expected to complete in Q2 2023 for company’s pivotal Phase 3 OnTarget clinical trial of crofelemer for prophylaxis of diarrhea in adult cancer patients receiving targeted therapySAN FRANCISCO…
Read More